A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the US

Part of paid clinical trials in South Gate, California.

Sponsor
Aurinia Pharmaceuticals Inc.
Study ID
NCT05337124
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • LUPKYNIS — DRUG
    LUPKYNIS treatment per the approved US Prescribing Information

Study Details

This registry is an observational study designed to assess the utilization and effectiveness of LUPKYNIS in adult patients with lupus nephritis (LN) in the United States (US).

Key Dates

Start date
Apr 5, 2022
Status verified
Jun 2025
Primary completion
Jan 31, 2025
Completion
Jan 31, 2025

Study Design

Enrollment
229 participants (actual)

Arms

  • Arm: Lupkynis Treatment Group

Primary Outcome Measure

LUPKYNIS utilization patterns [ Time Frame: 12 months (1 year) to 60 months (5 years) ]

Locations (1)

FacilityCityStateZIPSite coordinators
Site 00-05South GateCalifornia90280-

Find similar trials in South Gate, CA

By condition
Lupus (SLE)
By specialty
RheumatologyAutoimmune disease
By research site
Site 00-05· South Gate, CA

Related Studies